ArticleFrontiers in pediatrics2026
A nomogram for predicting the risk of bronchopulmonary dysplasia in preterm infants: a prospective multicenter study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bronchopulmonary dysplasia (BPD) is a common and serious complication in very preterm infants, with potential long-term adverse effects. This study aimed to analyze the perinatal and postnatal risk factors for BPD in preterm infants, and to develop and validate a risk model for early postnatal risk stratification based on information available within the first 7 days of life. Methods: Data on preterm infants with gestational age < 32 weeks were prospectively collected from 28 hospitals in Shenzhen from January 2022 to December 2023. Neonates admitted to the NICU of Peking University Shenzhen Hospital and Shenzhen People's Hospital were designated as the external validation cohort, whereas those from the other 26 NICUs were randomly divided into training and internal validation cohorts in an 8:2 ratio. BPD was the primary outcome and was diagnosed based on the 2018 revised criteria. Predictive factors were identified from the training cohort using logistic regression, and a nomogram model was constructed. Model performance was evaluated in terms of discrimination, calibration, and potential clinical utility. Results: A total of 1,336 preterm infants were included, with 801 in the training cohort, 214 in the internal validation cohort, and 321 in the external validation cohort. Among them, 259 infants (19.39%) were diagnosed with BPD. The nomogram model was based on six predictive factors: gestational age, birth weight (per 100 g increase), occurrence of preterm premature rupture of membranes (PPROM), antenatal corticosteroid (ACS) administration, early onset sepsis, and invasive mechanical ventilation (IMV) within the first seven days of life. The area under the curve (AUC)s were 0.812, 0.783, and 0.810 in the training, internal validation, and external validation cohorts, respectively, indicating acceptable discrimination. Calibration showed reasonable agreement between predicted and observed outcomes. Decision curve analysis suggested potential net benefit across a range of threshold probabilities, although clinical interpretation remains exploratory. Conclusion: This nomogram provides early postnatal risk stratification of BPD based on routinely available clinical information within the first week of life and may help identify preterm infants at higher risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.